Beneficial effects of training at the anaerobic threshold in addition to pharmacotherapy on weight loss, body composition, and exercise performance in women with obesity
| dc.contributor.author | Ozcelik, Oguz | |
| dc.contributor.author | Ozkan, Yusuf | |
| dc.contributor.author | Algul, Sermin | |
| dc.contributor.author | Colak, Ramis | |
| dc.date.accessioned | 2026-08-12T17:32:33Z | |
| dc.date.issued | 2015 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Objective: The aim of this study was to determine and compare the effects of weight loss achieved through orlistat therapy alone or a combination of orlistat and an aerobic exercise training program on aerobic fitness and body composition in obese females. Methods: Twenty-eight obese patients were randomly assigned to receive 12-week treatment with hypocaloric diet-orlistat or diet-orlistat-exercise. Each participant performed an incremental ramp exercise test every 4 weeks to measure aerobic fitness. Fourteen participants performed continuous exercise (approximately 45 minutes per session) at a work rate corresponding to the anaerobic threshold three times per week. Results: A decrease in the fat mass to body weight ratio of 3.8% (P=0.006) was observed at the end of the 12 weeks in the orlistat group, while a decrease of 9.5% (P=0.001) was seen in the orlistat-exercise group. Maximal exercise capacity increased by 46.5% in the orlistat-exercise group and by 19.5% in the orlistat group. Conclusion: While orlistat therapy resulted in an improvement in body composition and aerobic fitness at the end of the 12-week period, its combination with exercise training provided improvements in the same parameters within the first 4 weeks of the study. These additional beneficial effects of combining aerobic exercise with orlistat therapy are important with regards to obesity-associated risk factors. | |
| dc.identifier.doi | 10.2147/PPA.S84297 | |
| dc.identifier.endpage | 1004 | |
| dc.identifier.issn | 1177-889X | |
| dc.identifier.orcid | 0000-0002-2391-9883 | |
| dc.identifier.pmid | 26203232 | |
| dc.identifier.scopus | 2-s2.0-84937679502 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 999 | |
| dc.identifier.uri | https://doi.org/10.2147/PPA.S84297 | |
| dc.identifier.uri | https://hdl.handle.net/11508/56681 | |
| dc.identifier.volume | 9 | |
| dc.identifier.wos | WOS:000357879300005 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Dove Medical Press Ltd | |
| dc.relation.ispartof | Patient Preference and Adherence | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | obesity | |
| dc.subject | orlistat | |
| dc.subject | body mass index | |
| dc.subject | anaerobic threshold | |
| dc.subject | aerobic fitness | |
| dc.title | Beneficial effects of training at the anaerobic threshold in addition to pharmacotherapy on weight loss, body composition, and exercise performance in women with obesity | |
| dc.type | Article |







